Skip to content
Life Sciences Series A Founded 2017

Ribbon Biolabs

Developer of a technology platform for the synthesis of long DNA molecules. Developer of a technology platform for the synthesis of long DNA molecules. The company uses genetic solutions by the high-throughput synthesis of DNA. The company is focusing on libraries of DNAs of lengths of up to thousands of base pairs. The company is building genomes, high-throughput libraries, along with providing new products based…

📍 Vienna, Austria · Life Sciences Platforms and Tools,

Funding snapshot

Last roundSeries A
Amount$20M
Date31 January 2022
Total raised$20M
Team size63

About

Developer of a technology platform for the synthesis of long DNA molecules. Developer of a technology platform for the synthesis of long DNA molecules. The company uses genetic solutions by the high-throughput synthesis of DNA. The company is focusing on libraries of DNAs of lengths of up to thousands of base pairs. The company is building genomes, high-throughput libraries, along with providing new products based on DNA, storing data, computing with DNA, and building DNA-based nanotechnological devices. The company operates in the Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics sector. Founded in 2017 and headquartered in Vienna, Austria and has raised $20.1 million in Series A funding. Key investors include tecnet equity, Austria Wirtschaftsservice, xista, EIC Fund, Hadean Ventures, Lansdowne Partners, Helicase Venture, Europa.

Business model

Genomics > Applied Genomics > Synthetic Biology,

Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis > DNA

Institutional investors

tecnet equity Austria Wirtschaftsservice xista EIC Fund Hadean Ventures Lansdowne Partners Helicase Venture Europa Startup Live

Latest coverage

No articles yet.

Raising like Ribbon Biolabs?

Analyze your pitch deck before your next raise.

Analyze My Deck →